# Desmoteplase in Acute Ischemic Stroke (DIAS)

> **NCT00638781** · PHASE2 · COMPLETED · sponsor: **PAION Deutschland GmbH** · enrollment: 104 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Desmoteplase
- **DRUG:** Desmoteplase
- **DRUG:** Desmoteplase
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00638781
- **Lead sponsor:** PAION Deutschland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2003-10
- **Final completion:** 2003-10
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2008-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00638781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00638781, "Desmoteplase in Acute Ischemic Stroke (DIAS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00638781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*